Applied DNA Sciences, Inc. (BNBX) — Strategic Asset Allocation Index

Latest as of March 2026: 44.5%

Applied DNA Sciences, Inc. (BNBX) has a Strategic Asset Allocation Index of 44.5% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $5.40 Million) total $5.40 Million, measured against net assets of $12.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See financial flexibility index of Applied DNA Sciences, Inc. to measure the company's free cash flow as a share of total liabilities.

SAAI

44.5%

Strategic Assets / Net Assets

Strategic Assets

$5.40 Million

PP&E + LT Investments

PP&E

USD

Net Assets

$12.13 Million

USD

Annual Strategic Asset Allocation Index for Applied DNA Sciences, Inc. (None–None)

The table below presents the year-by-year Strategic Asset Allocation Index for Applied DNA Sciences, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BNBX market cap.

Year	SAAI	Strategic Assets (USD)	PP&E	LT Investments	Net Assets	Change (pp)

pp = percentage points